Eksentricity

Eksentricity

  • Home
  • Contact us

Healthcare & Biotech

AI Revolutionizes Neonatal Risk Assessment!

March 12, 2024
  • Share on LinkedIn (Opens in new window)LinkedIn
  • Share on X (Opens in new window)X
  • Share on Facebook (Opens in new window)Facebook
  • Share on Reddit (Opens in new window)Reddit
  • Share on Mail (Opens in new window)Mail
  • Machine Learning Predicts Newborn Risks: Utilized machine learning techniques, including Decision Trees and Bayesian Networks, to predict high-risk newborns’ outcomes based on antepartum and intrapartum risk factors, achieving up to 97.2% accuracy in APGAR score prediction.
  • Educational Tool Development: Aiming to create a user-friendly mobile application to assist neonatologists in the delivery room by improving recognition and planning for interventions on high-risk patients, leveraging machine-learned insights.
  • Model Validation and Impacts: Confirmed known medical correlations between risk factors and neonatal outcomes using machine learning, proposing a novel educational tool for real-time use in neonatal care to potentially enhance patient outcomes.

Impact:

  1. Enhanced Newborn Care: The tool could significantly improve neonatal outcomes by enabling timely and precise interventions for high-risk newborns.
  2. Educational Value for Neonatologists: Offers a practical, real-world training supplement, reinforcing knowledge and preparedness in neonatal care.
  3. Investment in Healthcare AI: Potential for increased investments in AI-driven healthcare solutions, recognizing their value in improving patient outcomes.
  4. Push for Data-Driven Healthcare: Encourages further adoption of data analytics and machine learning in healthcare, driving innovation and efficiency.
  5. Market Opportunity for Developers: Opens new avenues for software developers and companies specializing in healthcare applications, potentially expanding the market for medical mobile apps.

Read more

Recent news

  • US Markets Dip, FDA Boosts Tolebrutinib, and EVgo Secures $1.25B for Charging Growth

    US Markets Dip, FDA Boosts Tolebrutinib, and EVgo Secures $1.25B for Charging Growth

  • Pfizer Faces Investor Pressure, Bristol Myers Expands with Acquisitions, DOJ Eyes Google Breakup

    Pfizer Faces Investor Pressure, Bristol Myers Expands with Acquisitions, DOJ Eyes Google Breakup

  • Angel Kids AI Secures $1.1M in Seed Extension to Enhance Child-Safe AI Browser

    Angel Kids AI Secures $1.1M in Seed Extension to Enhance Child-Safe AI Browser

Eksentricity

  • LinkedIn
  • X

© 2024 Eksentricity. All rights reserved.

Privacy Policy

  • Reblog
  • Subscribe Subscribed
    • Eksentricity
    • Join 34 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Eksentricity
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar